TreeWAS – Variant ID: rs11199874

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability
N40 Hyperplasia of prostate	1.000	0.000
R33 Retention of urine	0.999	0.001
R79.8 Other specified abnormal findings of blood chemistry	0.998	0.002
N32 Other disorders of bladder	0.996	0.004
N32.8 Other specified disorders of bladder	0.995	0.005
R79 Other abnormal findings of blood chemistry	0.994	0.006
R30-R39 Symptoms and signs involving the urinary system	0.994	0.006
N32.3 Diverticulum of bladder	0.993	0.007
Chapter XVIII Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified	0.985	0.015
R70-R79 Abnormal findings on examination of blood, without diagnosis	0.985	0.015
R18 Ascites	0.979	0.021
N32.0 Bladder-neck obstruction	0.975	0.025
R31 Unspecified haematuria	0.956	0.044
R79.9 Abnormal finding of blood chemistry, unspecified	0.936	0.064
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue	0.931	0.069
R80-R82 Abnormal findings on examination of urine, without diagnosis	0.925	0.075
C82 Follicular [nodular] non-Hodgkin's lymphoma	0.920	0.080
N30-N39 Other diseases of urinary system	0.919	0.081
C85 Other and unspecified types of non-Hodgkin's lymphoma	0.916	0.084
C82.9 Follicular non-Hodgkin's lymphoma, unspecified	0.914	0.086
Chapter II Neoplasms	0.913	0.087
R83-R89 Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis	0.901	0.099
C76-C80 Malignant neoplasms of ill-defined, secondary and unspecified sites	0.896	0.104
C78 Secondary malignant neoplasm of respiratory and digestive organs	0.885	0.115
N40-N51 Diseases of male genital organs	0.885	0.115
C78.6 Secondary malignant neoplasm of retroperitoneum and peritoneum	0.884	0.116
R80 Isolated proteinuria	0.877	0.123
D00-D09 In situ neoplasms	0.875	0.125
C85.9 Non-Hodgkin's lymphoma, unspecified type	0.864	0.136
Chapter XIV Diseases of the genitourinary system	0.859	0.141
R86 Abnormal findings in specimens from male genital organs	0.857	0.143
N30 Cystitis	0.852	0.148
C85.1 B-cell lymphoma, unspecified	0.852	0.148
# Top node	0.845	0.155
N36 Other disorders of urethra	0.839	0.161
R90-R94 Abnormal findings on diagnostic imaging and in function studies, without diagnosis	0.837	0.163
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.834	0.166
D04 Carcinoma in situ of skin	0.829	0.171
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use	0.829	0.171
Y42.7 Androgens and anabolic congeners	0.826	0.174
Chapter XX External causes of morbidity and mortality	0.825	0.175
N30.2 Other chronic cystitis	0.811	0.189
C45-C49 Malignant neoplasms of mesothelial and soft tissue	0.810	0.190
N32.2 Vesical fistula, not elsewhere classified	0.810	0.190
D07 Carcinoma in situ of other and unspecified genital organs	0.810	0.190
C78.0 Secondary malignant neoplasm of lung	0.810	0.190
Y57 Other and unspecified drugs and medicaments	0.809	0.191
C00-C14 Malignant neoplasms of lip, oral cavity and pharynx	0.809	0.191
R36 Urethral discharge	0.809	0.191
R94 Abnormal results of function studies	0.806	0.194
R94.5 Abnormal results of liver function studies	0.796	0.204
C84 Peripheral and cutaneous T-cell lymphomas	0.795	0.205
N30.0 Acute cystitis	0.795	0.205
C40-C41 Malignant neoplasms of bone and articular cartilage	0.790	0.210
C15-C26 Malignant neoplasms of digestive organs	0.790	0.210
R81 Glycosuria	0.789	0.211
D04.5 Skin of trunk	0.783	0.217
Chapter VIII Diseases of the ear and mastoid process	0.776	0.224
C86 Other specified types of T/NK-cell lymphoma	0.773	0.227
C45 Mesothelioma	0.768	0.232
C91 Lymphoid leukaemia	0.768	0.232
C15 Malignant neoplasm of oesophagus	0.766	0.234
D00 Carcinoma in situ of oral cavity, oesophagus and stomach	0.766	0.234
N34 Urethritis and urethral syndrome	0.760	0.240
Y57.9 Drug or medicament, unspecified	0.760	0.240
C15.9 Oesophagus, unspecified	0.753	0.247
N43 Hydrocele and spermatocele	0.752	0.248
R92 Abnormal findings on diagnostic imaging of breast	0.750	0.250
N45 Orchitis and epididymitis	0.748	0.252
C83 Diffuse non-Hodgkin's lymphoma	0.747	0.253
Y00-Y09 Assault	0.741	0.259
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism	0.739	0.261
R83 Abnormal findings in cerebrospinal fluid	0.737	0.263
H90-H95 Other disorders of ear	0.736	0.264
C92 Myeloid leukaemia	0.732	0.268
N42 Other disorders of prostate	0.732	0.268
C95 Leukaemia of unspecified cell type	0.731	0.268
C02 Malignant neoplasm of other and unspecified parts of tongue	0.731	0.269
C90 Multiple myeloma and malignant plasma cell neoplasms	0.730	0.270
N36.0 Urethral fistula	0.730	0.270
Y57.8 Other drugs and medicaments	0.729	0.271
N32.1 Vesicointestinal fistula	0.728	0.272
Y42.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.727	0.273
R86.9 Unspecified abnormal finding	0.727	0.273
Y42.5 Other oestrogens and progestogens	0.725	0.275
R86.0 Abnormal level of enzymes	0.723	0.277
D37-D48 Neoplasms of uncertain or unknown behaviour	0.722	0.278
C77 Secondary and unspecified malignant neoplasm of lymph nodes	0.720	0.280
D04.9 Skin, unspecified	0.719	0.281
R86.5 Abnormal microbiological findings	0.719	0.281
D07.1 Vulva	0.716	0.284
N32.4 Rupture of bladder, nontraumatic	0.714	0.286
R34 Anuria and oliguria	0.714	0.286
Y51 Drugs primarily affecting the autonomic nervous system	0.714	0.286
H65-H75 Diseases of middle ear and mastoid	0.713	0.287
D07.4 Penis	0.710	0.290
Y42.1 Thyroid hormones and substitutes	0.709	0.291
C83.3 Large cell (diffuse)	0.709	0.291
R95-R99 Ill-defined and unknown causes of mortality	0.707	0.293
R75 Laboratory evidence of human immunodeficiency virus [HIV]	0.706	0.294
R86.6 Abnormal cytological findings	0.706	0.294
C77.5 Intrapelvic lymph nodes	0.705	0.295
C85.7 Other specified types of non-Hodgkin's lymphoma	0.705	0.295
C41 Malignant neoplasm of bone and articular cartilage of other and unspecified sites	0.704	0.296
C50-C50 Malignant neoplasm of breast	0.700	0.300
H92 Otalgia and effusion of ear	0.700	0.300
C14 Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx	0.700	0.300
R78 Findings of drugs and other substances, not normally found in blood	0.698	0.302
C16 Malignant neoplasm of stomach	0.693	0.307
D04.6 Skin of upper limb, including shoulder	0.692	0.308
Chapter XXII Codes for special purposes	0.691	0.309
R84 Abnormal findings in specimens from respiratory organs and thorax	0.689	0.311
V40-V49 Car occupant injured in transport accident	0.687	0.312
Y04 Assault by bodily force	0.687	0.313
H73 Other disorders of tympanic membrane	0.687	0.313
C07 Malignant neoplasm of parotid gland	0.686	0.313
C82.4 Follicular lymphoma grade IIIb	0.686	0.314
N36.8 Other specified disorders of urethra	0.686	0.314
R25-R29 Symptoms and signs involving the nervous and musculoskeletal systems	0.684	0.316
C78.3 Secondary malignant neoplasm of other and unspecified respiratory organs	0.682	0.318
N43.3 Hydrocele, unspecified	0.682	0.318
N42.9 Disorder of prostate, unspecified	0.681	0.319
C78.5 Secondary malignant neoplasm of large intestine and rectum	0.678	0.322
R94.6 Abnormal results of thyroid function studies	0.672	0.328
N51 Disorders of male genital organs in diseases classified elsewhere	0.672	0.328
D40 Neoplasm of uncertain or unknown behaviour of male genital organs	0.672	0.328
D07.2 Vagina	0.671	0.329
N30.1 Interstitial cystitis (chronic)	0.670	0.330
W00-W19 Falls	0.669	0.331
C25 Malignant neoplasm of pancreas	0.669	0.331
C80 Malignant neoplasm without specification of site	0.668	0.332
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.667	0.332
C94 Other leukaemias of specified cell type	0.667	0.332
C82.0 Small cleaved cell, follicular	0.666	0.334
D00.1 Oesophagus	0.666	0.334
R71 Abnormality of red blood cells	0.664	0.336
Y42.2 Antithyroid drugs	0.664	0.336
C15.0 Cervical part of oesophagus	0.662	0.338
C84.5 Other and unspecified T-cell lymphomas	0.661	0.339
C82.6 Cutaneous follicle centre lymphoma	0.660	0.340
C82.5 Diffuse follicle centre lymphoma	0.660	0.340
C86.5 Angioimmunoblastic T-cell lymphoma	0.659	0.341
D46 Myelodysplastic syndromes	0.659	0.341
R30 Pain associated with micturition	0.659	0.341
N37 Urethral disorders in diseases classified elsewhere	0.659	0.341
N33 Bladder disorders in diseases classified elsewhere	0.659	0.341
Y42.9 Other and unspecified hormone antagonists	0.659	0.341
R86.7 Abnormal histological findings	0.658	0.342
R72 Abnormality of white blood cells, not elsewhere classified	0.658	0.342
C85.2 Mediastinal (thymic) large B-cell lymphoma	0.657	0.343
C85.0 Lymphosarcoma	0.657	0.343
W75-W84 Other accidental threats to breathing	0.656	0.343
R94.7 Abnormal results of other endocrine function studies	0.656	0.344
R89 Abnormal findings in specimens from other organs, systems and tissues	0.654	0.345
D09 Carcinoma in situ of other and unspecified sites	0.653	0.347
C82.3 Follicular lymphoma grade IIIa	0.652	0.347
Y54.3 Benzothiadiazine derivatives	0.652	0.348
H72 Perforation of tympanic membrane	0.651	0.349
H92.0 Otalgia	0.651	0.349
C45.7 Mesothelioma of other sites	0.651	0.349
R70 Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity	0.650	0.350
H73.8 Other specified disorders of tympanic membrane	0.650	0.350
D02 Carcinoma in situ of middle ear and respiratory system	0.648	0.352
N45.0 Orchitis, epididymitis and epididymo-orchitis with abscess	0.645	0.354
C45.1 Mesothelioma of peritoneum	0.645	0.355
C82.1 Mixed small cleaved and large cell, follicular	0.645	0.355
C45.9 Mesothelioma, unspecified	0.644	0.356
C91.4 Hairy-cell leukaemia	0.642	0.358
C79 Secondary malignant neoplasm of other sites	0.640	0.360
C84.4 Peripheral T-cell lymphoma	0.640	0.360
X20-X29 Contact with venomous animals and plants	0.638	0.361
Y70-Y82 Medical devices associated with adverse incidents in diagnostic and therapeutic use	0.638	0.362
V10-V19 Pedal cyclist injured in transport accident	0.638	0.362
N30.4 Irradiation cystitis	0.638	0.362
V60-V69 Occupant of heavy transport vehicle injured in transport accident	0.635	0.365
N44 Torsion of testis	0.634	0.365
C82.7 Other types of follicular non-Hodgkin's lymphoma	0.634	0.366
N36.9 Urethral disorder, unspecified	0.633	0.367
C78.7 Secondary malignant neoplasm of liver	0.632	0.368
C91.1 Chronic lymphocytic leukaemia	0.632	0.368
C82.2 Large cell, follicular	0.631	0.368
R10-R19 Symptoms and signs involving the digestive system and abdomen	0.632	0.368
R26 Abnormalities of gait and mobility	0.631	0.369
Y57.5 X-ray contrast media	0.631	0.369
N36.1 Urethral diverticulum	0.630	0.370
V90-V94 Water transport accidents	0.630	0.370
Y53 Agents primarily affecting the gastro-intestinal system	0.629	0.371
V49 Car occupant injured in other and unspecified transport accidents	0.629	0.371
C25.0 Head of pancreas	0.629	0.371
W08 Fall involving other furniture	0.628	0.372
Y41 Other systemic anti-infectives and antiparasitics	0.625	0.375
N34.3 Urethral syndrome, unspecified	0.623	0.377
D04.1 Skin of eyelid, including canthus	0.623	0.377
C93 Monocytic leukaemia	0.622	0.378
N48 Other disorders of penis	0.622	0.378
N36.2 Urethral caruncle	0.622	0.378
C00 Malignant neoplasm of lip	0.621	0.379
C14.0 Pharynx, unspecified	0.621	0.379
R83.8 Other abnormal findings	0.621	0.379
C92.5 Acute myelomonocytic leukaemia	0.620	0.380
D04.4 Skin of scalp and neck	0.620	0.380
V01-V09 Pedestrian injured in transport accident	0.620	0.380
Y58 Bacterial vaccines	0.618	0.382
R76 Other abnormal immunological findings in serum	0.616	0.384
R86.4 Abnormal immunological findings	0.614	0.386
R86.3 Abnormal level of substances chiefly nonmedicinal as to source	0.614	0.386
R86.2 Abnormal level of other drugs, medicaments and biological substances	0.614	0.386
R86.1 Abnormal level of hormones	0.614	0.386
D40.0 Prostate	0.614	0.386
R77 Other abnormalities of plasma proteins	0.614	0.386
D03 Melanoma in situ	0.614	0.386
H92.1 Otorrhoea	0.613	0.387
R79.0 Abnormal level of blood mineral	0.612	0.387
R74 Abnormal serum enzyme levels	0.612	0.388
Chapter XVI Certain conditions originating in the perinatal period	0.612	0.388
Y47 Sedatives, hypnotics and antianxiety drugs	0.611	0.389
H93 Other disorders of ear, not elsewhere classified	0.609	0.391
Y42.6 Antigonadotrophins, antioestrogens, antiandrogens, not elsewhere classified	0.608	0.392
C80.0 Malignant neoplasm, primary site unknown, so stated	0.607	0.393
C78.1 Secondary malignant neoplasm of mediastinum	0.607	0.393
C77.2 Intra-abdominal lymph nodes	0.607	0.393
C77.8 Lymph nodes of multiple regions	0.606	0.394
C02.9 Tongue, unspecified	0.606	0.394
H72.8 Other perforations of tympanic membrane	0.606	0.394
C90.3 Solitary plasmacytoma	0.605	0.395
H90 Conductive and sensorineural hearing loss	0.605	0.395
N46 Male infertility	0.605	0.395
C02.1 Border of tongue	0.605	0.395
C20 Malignant neoplasm of rectum	0.604	0.396
C10 Malignant neoplasm of oropharynx	0.603	0.397
C03 Malignant neoplasm of gum	0.602	0.398
W08.0 Home	0.602	0.398
Y83-Y84 Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure	0.602	0.398
N42.1 Congestion and haemorrhage of prostate	0.602	0.398
C24 Malignant neoplasm of other and unspecified parts of biliary tract	0.602	0.398
Y04.2 School, other institution and public administrative area	0.601	0.399
D04.7 Skin of lower limb, including hip	0.600	0.400
Y42.4 Oral contraceptives	0.598	0.402
Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism	0.597	0.403
C06 Malignant neoplasm of other and unspecified parts of mouth	0.597	0.403
C45.0 Mesothelioma of pleura	0.596	0.404
C16.0 Cardia	0.596	0.404
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system	0.596	0.404
D00.0 Lip, oral cavity and pharynx	0.595	0.405
R85 Abnormal findings in specimens from digestive organs and abdominal cavity	0.595	0.405
D04.8 Skin of other sites	0.594	0.405
D04.0 Skin of lip	0.594	0.405
Y90-Y98 Supplementary factors related to causes of morbidity and mortality classified elsewhere	0.594	0.405
Y50 Central nervous system stimulants, not elsewhere classified	0.594	0.406
R35 Polyuria	0.592	0.408
Y35-Y36 Legal intervention and operations of war	0.592	0.408
X85-X99 Assault	0.592	0.408
X30-X39 Exposure to forces of nature	0.592	0.408
W65-W74 Accidental drowning and submersion	0.592	0.408
V50-V59 Occupant of pick-up truck or van injured in transport accident	0.592	0.408
V30-V39 Occupant of three-wheeled motor vehicle injured in transport accident	0.592	0.408
R90 Abnormal findings on diagnostic imaging of central nervous system	0.589	0.411
C12 Malignant neoplasm of pyriform sinus	0.588	0.411
D01 Carcinoma in situ of other and unspecified digestive organs	0.588	0.412
R94.2 Abnormal results of pulmonary function studies	0.587	0.413
R30.0 Dysuria	0.586	0.414
C95.1 Chronic leukaemia of unspecified cell type	0.586	0.414
D55-D59 Haemolytic anaemias	0.582	0.418
C90.2 Plasmacytoma, extramedullary	0.582	0.418
N34.2 Other urethritis	0.582	0.418
C47 Malignant neoplasm of peripheral nerves and autonomic nervous system	0.581	0.419
C46 Kaposi's sarcoma	0.581	0.419
C22 Malignant neoplasm of liver and intrahepatic bile ducts	0.581	0.419
D07.6 Other and unspecified male genital organs	0.581	0.419
D07.3 Other and unspecified female genital organs	0.581	0.419
D07.0 Endometrium	0.581	0.419
C41.0 Bones of skull and face	0.581	0.419
Y57.7 Vitamins, not elsewhere classified	0.580	0.420
Y57.4 Pharmaceutical excipients	0.580	0.420
Y57.3 Alcohol deterrents	0.580	0.420
Y57.2 Antidotes and chelating agents, not elsewhere classified	0.580	0.420
Y57.1 Lipotropic drugs	0.580	0.420
Y57.0 Appetite depressants [anorectics]	0.580	0.420
Y10-Y34 Event of undetermined intent	0.580	0.420
C13 Malignant neoplasm of hypopharynx	0.580	0.420
R26.0 Ataxic gait	0.580	0.420
N48.2 Other inflammatory disorders of penis	0.578	0.422
R94.1 Abnormal results of function studies of peripheral nervous system and special senses	0.578	0.422
U82-U85 Resistance to antimicrobial and antineoplastic drugs	0.578	0.422
C91.0 Acute lymphoblastic leukaemia	0.577	0.423
X58-X59 Accidental exposure to other and unspecified factors	0.577	0.423
Y54.4 Loop [high-ceiling] diuretics	0.577	0.423
Y42.8 Other and unspecified hormones and their synthetic substitutes	0.577	0.423
R39 Other symptoms and signs involving the urinary system	0.577	0.423
C41.1 Mandible	0.576	0.424
C92.9 Myeloid leukaemia, unspecified	0.575	0.425
W03 Other fall on same level due to collision with, or pushing by, another person	0.575	0.425
Y59 Other and unspecified vaccines and biological substances	0.572	0.428
V19 Pedal cyclist injured in other and unspecified transport accidents	0.571	0.429
D43 Neoplasm of uncertain or unknown behaviour of brain and central nervous system	0.571	0.429
C84.9 Mature T/NK-cell lymphoma, unspecified	0.570	0.430
C84.8 Cutaneous T-cell lymphoma, unspecified	0.570	0.430
C84.7 Anaplastic large cell lymphoma, ALK-negative	0.570	0.430
C84.6 Anaplastic large cell lymphoma, ALK-positive	0.570	0.430
C84.3 Lymphoepithelioid lymphoma	0.570	0.430
C84.2 T-zone lymphoma	0.570	0.430
C84.1 Sezary's diease	0.570	0.430
Y51.3 Other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, not elsewhere classified	0.569	0.431
Y57.6 Other diagnostic agents	0.568	0.431
Y04.8 Other specified place	0.568	0.431
C42 hematopoietic and reticuloendothelial systems (ICD-O-3 specific)	0.567	0.433
Y46 Antiepileptics and anti-Parkinsonism drugs	0.566	0.433
H73.1 Chronic myringitis	0.566	0.434
N36.3 Prolapsed urethral mucosa	0.566	0.434
C02.4 Lingual tonsil	0.566	0.434
C16.9 Stomach, unspecified	0.565	0.435
Y51.6 @-Adrenoreceptor antagonists, not elsewhere classified	0.565	0.435
C41.2 Vertebral column	0.565	0.435
X00-X09 Exposure to smoke, fire and flames	0.565	0.435
D59 Acquired haemolytic anaemia	0.564	0.436
Y84.8 Other medical procedures	0.564	0.436
C04 Malignant neoplasm of floor of mouth	0.564	0.436
C40 Malignant neoplasm of bone and articular cartilage of limbs	0.563	0.437
C84.0 Mycosis fungoides	0.561	0.439
D41 Neoplasm of uncertain or unknown behaviour of urinary organs	0.561	0.439
D46.7 Other myelodysplastic syndromes	0.561	0.439
Y54.1 Mineralocorticoid antagonists [aldosterone antagonists]	0.559	0.441
W85-W99 Exposure to electric current, radiation and extreme ambient air temperature and pressure	0.559	0.441
V98-V99 Other and unspecified transport accidents	0.558	0.442
N43.2 Other hydrocele	0.558	0.442
Y84 Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure	0.557	0.443
D45 Polycythaemia vera	0.555	0.445
R26.2 Difficulty in walking, not elsewhere classified	0.554	0.446
C86.6 Primary cutaneous CD30-positive T-cell proliferations	0.554	0.446
C86.4 Blastic NK-cell lymphoma	0.554	0.446
C86.3 Subcutaneous panniculitis-like T-cell lymphoma	0.554	0.446
C86.2 Enteropathy-type (intestinal) T-cell lymphoma	0.554	0.446
C86.1 Hepatosplenic T-cell lymphoma	0.554	0.446
C86.0 Extranodal NK/T-cell lymphoma, nasal type	0.554	0.446
N48.4 Impotence of organic origin	0.553	0.447
C25.1 Body of pancreas	0.553	0.447
D40.1 Testis	0.553	0.447
C15.3 Upper third of oesophagus	0.553	0.447
D46.2 Refractory anaemia with excess of blasts	0.553	0.447
C90.1 Plasma cell leukaemia	0.552	0.448
C79.0 Secondary malignant neoplasm of kidney and renal pelvis	0.552	0.448
C45.2 Mesothelioma of pericardium	0.551	0.449
C91.8 Mature B-cell leukaemia Burkitt-type	0.550	0.450
C91.7 Other lymphoid leukaemia	0.550	0.450
C91.6 Prolymphocytic leukaemia of T-cell type	0.550	0.450
C91.3 Prolymphocytic leukaemia	0.550	0.450
C91.2 Subacute lymphocytic leukaemia	0.550	0.450
Y51.7 Beta-Adrenoreceptor antagonists, not elsewhere classified	0.550	0.450
C15.8 Overlapping lesion of oesophagus	0.549	0.451
C15.2 Abdominal part of oesophagus	0.549	0.451
C15.1 Thoracic part of oesophagus	0.549	0.451
V95-V97 Air and space transport accidents	0.549	0.451
D00.2 Stomach	0.549	0.451
C50 Malignant neoplasm of breast	0.548	0.452
N48.9 Disorder of penis, unspecified	0.547	0.453
Y54.5 Other diuretics	0.547	0.453
C50.3 Lower-inner quadrant of breast	0.546	0.454
C17 Malignant neoplasm of small intestine	0.546	0.454
D70-D77 Other diseases of blood and blood-forming organs	0.546	0.454
C97-C97 Malignant neoplasms of independent (primary) multiple sites	0.545	0.455
N34.1 Nonspecific urethritis	0.545	0.455
N34.0 Urethral abscess	0.545	0.455
N45.9 Orchitis, epididymitis and epididymo-orchitis without abscess	0.545	0.455
C02.2 Ventral surface of tongue	0.544	0.456
H72.1 Attic perforation of tympanic membrane	0.543	0.457
V70-V79 Bus occupant injured in transport accident	0.543	0.457
V49.9 Car occupant [any] injured in unspecified traffic accident	0.543	0.457
C16.2 Body of stomach	0.542	0.458
Y04.5 Trade and service area	0.542	0.458
D59.1 Other autoimmune haemolytic anaemias	0.541	0.459
W13 Fall from, out of or through building or structure	0.541	0.459
R47-R49 Symptoms and signs involving speech and voice	0.540	0.460
D03.6 Melanoma in situ of upper limb, including shoulder	0.540	0.460
Y41.0 Sulphonamides	0.540	0.460
N43.1 Infected hydrocele	0.539	0.461
N43.0 Encysted hydrocele	0.539	0.461
H90.8 Mixed conductive and sensorineural hearing loss, unspecified	0.539	0.461
C48 Malignant neoplasm of retroperitoneum and peritoneum	0.539	0.461
W11 Fall on and from ladder	0.538	0.462
V49.4 Driver injured in collision with other and unspecified motor vehicles in traffic accident	0.537	0.463
C83.6 Undifferentiated (diffuse)	0.535	0.464
C83.5 Lymphoblastic (diffuse)	0.535	0.464
C83.4 Immunoblastic (diffuse)	0.535	0.464
C83.2 Mixed small and large cell (diffuse)	0.535	0.464
V20-V29 Motorcycle rider injured in transport accident	0.535	0.465
Y00 Assault by blunt object	0.534	0.466
Y07 Other maltreatment syndromes	0.533	0.467
D46.9 Myelodysplastic syndrome, unspecified	0.533	0.467
C88 Malignant immunoproliferative diseases	0.532	0.468
Y08 Assault by other specified means	0.531	0.469
Y06 Neglect and abandonment	0.531	0.469
Y05 Sexual assault by bodily force	0.531	0.469
Y03 Assault by crashing of motor vehicle	0.531	0.469
Y02 Assault by pushing or placing victim before moving object	0.531	0.469
Y01 Assault by pushing from high place	0.531	0.469
Y40 Systemic antibiotics	0.531	0.469
Y54.9 Mineral salts, not elsewhere classified	0.530	0.470
Y54.7 Agents affecting calcification	0.530	0.470
Y54.6 Electrolytic, caloric and water-balance agents	0.530	0.470
Y54.2 Carbonic-anhydrase inhibitors	0.530	0.470
Y54.0 Mineralocorticoids	0.530	0.470
R83.9 Unspecified abnormal finding	0.529	0.471
R83.7 Abnormal histological findings	0.529	0.471
R83.6 Abnormal cytological findings	0.529	0.471
R83.5 Abnormal microbiological findings	0.529	0.471
R83.4 Abnormal immunological findings	0.529	0.471
R83.3 Abnormal level of substances chiefly nonmedicinal as to source	0.529	0.471
R83.2 Abnormal level of other drugs, medicaments and biological substances	0.529	0.471
R83.1 Abnormal level of hormones	0.529	0.471
R83.0 Abnormal level of enzymes	0.529	0.471
C95.9 Leukaemia, unspecified	0.528	0.471
H73.9 Disorder of tympanic membrane, unspecified	0.528	0.472
H94 Other disorders of ear in diseases classified elsewhere	0.528	0.472
C92.4 Acute promyelocytic leukaemia	0.528	0.472
H72.0 Central perforation of tympanic membrane	0.528	0.472
U89 Agent resistant to other and unspecified antibiotics	0.527	0.473
H90.1 Conductive hearing loss, unilateral with unrestricted hearing on the contralateral side	0.527	0.473
R84.5 Abnormal microbiological findings	0.527	0.473
R94.0 Abnormal results of function studies of central nervous system	0.525	0.474
C92.8 Acute myeloid leukaemia with multilineage dysplasia	0.525	0.475
C92.7 Other myeloid leukaemia	0.525	0.475
C92.6 Acute myeloid leukaemia with 11q23-abnormality	0.525	0.475
C92.3 Myeloid sarcoma	0.525	0.475
C92.2 Subacute myeloid leukaemia	0.525	0.475
N42.3 Dysplasia of prostate	0.525	0.475
C95.7 Other leukaemia of unspecified cell type	0.524	0.475
C95.2 Subacute leukaemia of unspecified cell type	0.524	0.475
C95.0 Acute leukaemia of unspecified cell type	0.524	0.475
C02.8 Overlapping lesion of tongue	0.524	0.476
C02.3 Anterior two-thirds of tongue, part unspecified	0.524	0.476
C02.0 Dorsal surface of tongue	0.524	0.476
C92.0 Acute myeloid leukaemia	0.524	0.476
V19.3 Pedal cyclist [any] injured in an unspecified nontraffic accident	0.523	0.477
C08 Malignant neoplasm of other and unspecified major salivary glands	0.522	0.478
Y85-Y89 Sequelae of external causes of morbidity and mortality	0.522	0.478
Y51.9 Other and unspecified drugs primarily affecting the autonomic nervous system	0.522	0.478
Y44 Agents primarily affecting blood constituents	0.520	0.480
Y42.0 Glucocorticoids and synthetic analogs	0.520	0.480
C16.6 Greater curvature of stomach, unspecified	0.519	0.480
C01 Malignant neoplasm of base of tongue	0.519	0.481
N51.2 Balanitis in diseases classified elsewhere	0.519	0.481
D42 Neoplasm of uncertain or unknown behaviour of meninges	0.518	0.482
D09.1 Other and unspecified urinary organs	0.517	0.483
C51-C58 Malignant neoplasms of female genital organs	0.517	0.483
Y48 Anaesthetics and therapeutic gases	0.517	0.483
C79.9 Secondary malignant neoplasm, unspecified site	0.516	0.484
D70 Agranulocytosis	0.515	0.485
R84.7 Abnormal histological findings	0.515	0.485
C16.1 Fundus of stomach	0.514	0.486
X10-X19 Contact with heat and hot substances	0.513	0.487
R39.1 Other difficulties with micturition	0.513	0.487
Y51.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.512	0.488
Y51.8 Centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified	0.512	0.488
Y51.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.512	0.488
Y51.2 Ganglionic blocking drugs, not elsewhere classified	0.512	0.488
Y51.1 Other parasympathomimetics [cholinergics]	0.512	0.488
Y51.0 Anticholinesterase agents	0.512	0.488
H93.3 Disorders of acoustic nerve	0.512	0.488
V09 Pedestrian injured in other and unspecified transport accidents	0.512	0.488
H75 Other disorders of middle ear and mastoid in diseases classified elsewhere	0.511	0.489
H68 Eustachian salpingitis and obstruction	0.511	0.489
H67 Otitis media in diseases classified elsewhere	0.511	0.489
C79.1 Secondary malignant neoplasm of bladder and other and unspecified urinary organs	0.510	0.489
H93.9 Disorder of ear, unspecified	0.510	0.490
W78 Inhalation of gastric contents	0.510	0.490
W80 Inhalation and ingestion of other objects causing obstruction of respiratory tract	0.510	0.490
W02 Fall involving ice-skates, skis, roller-skates or skateboards	0.509	0.490
N42.8 Other specified disorders of prostate	0.509	0.491
Y79 Orthopaedic devices associated with adverse incidents	0.508	0.492
W01 Fall on same level from slipping, tripping and stumbling	0.507	0.493
R96 Other sudden death, cause unknown	0.507	0.493
R95 Sudden infant death syndrome	0.507	0.493
R99 Other ill-defined and unspecified causes of mortality	0.507	0.493
R98 Unattended death	0.507	0.493
C11 Malignant neoplasm of nasopharynx	0.505	0.495
C41.8 Overlapping lesion of bone and articular cartilage	0.505	0.495
C41.3 Ribs, sternum and clavicle	0.505	0.495
X23 Contact with hornets, wasps and bees	0.505	0.495
H95 Postprocedural disorders of ear and mastoid process, not elsewhere classified	0.503	0.496
R78.8 Finding of other specified substances, not normally found in blood	0.503	0.497
W50-W64 Exposure to animate mechanical forces	0.503	0.497
H74 Other disorders of middle ear and mastoid	0.503	0.497
C41.9 Bone and articular cartilage, unspecified	0.502	0.498
C14.8 Overlapping lesion of lip, oral cavity and pharynx	0.502	0.498
C14.2 Waldeyer's ring	0.502	0.498
W09 Fall involving playground equipment	0.502	0.498
Y09 Assault by unspecified means	0.501	0.499
U00-U49 Provisional assignment of new diseases of uncertain etiology or emergency use	0.501	0.499
C91.5 Adult T-cell leukaemia	0.501	0.499
R78.9 Finding of unspecified substance, not normally found in blood	0.500	0.500
R78.7 Finding of abnormal level of heavy metals in blood	0.500	0.500
R78.6 Finding of steroid agent in blood	0.500	0.500
R78.5 Finding of psychotropic drug in blood	0.500	0.500
R78.4 Finding of other drugs of addictive potential in blood	0.500	0.500
R78.3 Finding of hallucinogen in blood	0.500	0.500
R78.2 Finding of cocaine in blood	0.500	0.500
R78.1 Finding of opiate drug in blood	0.500	0.500
D72 Other disorders of white blood cells	0.500	0.500
C83.0 Small cell (diffuse)	0.499	0.501
V69 Occupant of heavy transport vehicle injured in other and unspecified transport accidents	0.498	0.501

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations